932 related articles for article (PubMed ID: 22928023)
21. Regulating the Regulators: Mechanisms of Substrate Selection of the O-GlcNAc Cycling Enzymes OGT and OGA.
Stephen HM; Adams TM; Wells L
Glycobiology; 2021 Aug; 31(7):724-733. PubMed ID: 33498085
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional regulation of
Qian K; Wang S; Fu M; Zhou J; Singh JP; Li MD; Yang Y; Zhang K; Wu J; Nie Y; Ruan HB; Yang X
J Biol Chem; 2018 Sep; 293(36):13989-14000. PubMed ID: 30037904
[TBL] [Abstract][Full Text] [Related]
23. Pregnancy decreases O-GlcNAc-modified proteins in systemic arteries of normotensive and spontaneously hypertensive rats.
Troiano JA; Potje SR; Graton ME; Silva DS; da Costa RM; Tostes RC; Antoniali C
Life Sci; 2021 Feb; 266():118885. PubMed ID: 33316265
[TBL] [Abstract][Full Text] [Related]
24. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells.
Sermikli BP; Aydogdu G; Yilmaz E
Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273
[TBL] [Abstract][Full Text] [Related]
25. The O-GlcNAc dichotomy: when does adaptation become pathological?
Costa TJ; Wilson EW; Fontes MT; Pernomian L; Tostes RC; Wenceslau CF; McCarthy CG
Clin Sci (Lond); 2023 Nov; 137(22):1683-1697. PubMed ID: 37986614
[TBL] [Abstract][Full Text] [Related]
26. OGT and OGA expression in postmenopausal skeletal muscle associates with hormone replacement therapy and muscle cross-sectional area.
Toivonen MH; Pöllänen E; Ahtiainen M; Suominen H; Taaffe DR; Cheng S; Takala T; Kujala UM; Tammi MI; Sipilä S; Kovanen V
Exp Gerontol; 2013 Dec; 48(12):1501-4. PubMed ID: 24365779
[TBL] [Abstract][Full Text] [Related]
27. A mitotic GlcNAcylation/phosphorylation signaling complex alters the posttranslational state of the cytoskeletal protein vimentin.
Slawson C; Lakshmanan T; Knapp S; Hart GW
Mol Biol Cell; 2008 Oct; 19(10):4130-40. PubMed ID: 18653473
[TBL] [Abstract][Full Text] [Related]
28. O-Linked N-Acetylglucosamine (O-GlcNAc) Transferase and O-GlcNAcase Interact with Mi2β Protein at the Aγ-Globin Promoter.
Zhang Z; Costa FC; Tan EP; Bushue N; DiTacchio L; Costello CE; McComb ME; Whelan SA; Peterson KR; Slawson C
J Biol Chem; 2016 Jul; 291(30):15628-40. PubMed ID: 27231347
[TBL] [Abstract][Full Text] [Related]
29. Insights into O-linked N-acetylglucosamine ([0-9]O-GlcNAc) processing and dynamics through kinetic analysis of O-GlcNAc transferase and O-GlcNAcase activity on protein substrates.
Shen DL; Gloster TM; Yuzwa SA; Vocadlo DJ
J Biol Chem; 2012 May; 287(19):15395-408. PubMed ID: 22311971
[TBL] [Abstract][Full Text] [Related]
30. A genetic model to study
St Amand MM; Bond MR; Riedy J; Comly M; Shiloach J; Hanover JA
J Biol Chem; 2018 Aug; 293(35):13673-13681. PubMed ID: 29954943
[No Abstract] [Full Text] [Related]
31. Sustained
Tan EP; McGreal SR; Graw S; Tessman R; Koppel SJ; Dhakal P; Zhang Z; Machacek M; Zachara NE; Koestler DC; Peterson KR; Thyfault JP; Swerdlow RH; Krishnamurthy P; DiTacchio L; Apte U; Slawson C
J Biol Chem; 2017 Sep; 292(36):14940-14962. PubMed ID: 28739801
[TBL] [Abstract][Full Text] [Related]
32. Exploiting O-GlcNAc transferase promiscuity to dissect site-specific O-GlcNAcylation.
Mitchell CW; Galan Bartual S; Ferenbach AT; Scavenius C; van Aalten DMF
Glycobiology; 2023 Dec; 33(12):1172-1181. PubMed ID: 37856504
[TBL] [Abstract][Full Text] [Related]
33. Acutely elevated O-GlcNAcylation suppresses hippocampal activity by modulating both intrinsic and synaptic excitability factors.
Hwang H; Rhim H
Sci Rep; 2019 May; 9(1):7287. PubMed ID: 31086206
[TBL] [Abstract][Full Text] [Related]
34. O-GlcNAc transferase and O-GlcNAcase: achieving target substrate specificity.
Nagel AK; Ball LE
Amino Acids; 2014 Oct; 46(10):2305-16. PubMed ID: 25173736
[TBL] [Abstract][Full Text] [Related]
35. Ac
Wang H; Guo J; Wang N; Wang J; Xue Q; Wang J; Liu W; Liu K; Cao X; Zhao W; Xi R; Niu Y; Wang P; Li J
Bioorg Med Chem Lett; 2019 Mar; 29(6):802-805. PubMed ID: 30713024
[TBL] [Abstract][Full Text] [Related]
36. O-GlcNAcylation of RBM14 contributes to elevated cellular O-GlcNAc through regulation of OGA protein stability.
Kweon TH; Jung H; Ko JY; Kang J; Kim W; Kim Y; Kim HB; Yi EC; Ku NO; Cho JW; Yang WH
Cell Rep; 2024 May; 43(5):114163. PubMed ID: 38678556
[TBL] [Abstract][Full Text] [Related]
37. Drosophila O-GlcNAcase Deletion Globally Perturbs Chromatin O-GlcNAcylation.
Akan I; Love DC; Harwood KR; Bond MR; Hanover JA
J Biol Chem; 2016 May; 291(19):9906-19. PubMed ID: 26957542
[TBL] [Abstract][Full Text] [Related]
38. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
Phueaouan T; Chaiyawat P; Netsirisawan P; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2013 Dec; 30(6):2929-36. PubMed ID: 24126823
[TBL] [Abstract][Full Text] [Related]
39. Potential coordination role between O-GlcNAcylation and epigenetics.
Wu D; Cai Y; Jin J
Protein Cell; 2017 Oct; 8(10):713-723. PubMed ID: 28488246
[TBL] [Abstract][Full Text] [Related]
40. O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice.
Makino A; Dai A; Han Y; Youssef KD; Wang W; Donthamsetty R; Scott BT; Wang H; Dillmann WH
Am J Physiol Cell Physiol; 2015 Nov; 309(9):C593-9. PubMed ID: 26269457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
